Publications

Members only publications are marked with a lock icon:
Filter By
JAMDA
April 27, 2021
Challenges inherent in the practice of continuous palliative sedation until death appear to be particularly pervasive in nursing homes. We aimed to develop a protocol to improve the quality of the practice in Belgian nursing homes.
JAMDA
April 26, 2021
Many older adults prefer to live independently at home as long as possible.1 Home is also where people want to be in the final days of their lives.2 Aging in place at home provides a sense of attachment and security to older adults as well as a...
JAMDA
April 26, 2021
Sarcopenia is a risk factor for poor outcomes in older adults. Identification of plasma markers may facilitate screening of sarcopenia. We previously reported that creatinine-to-cystatin C ratio is a simple marker of muscle mass. To further assess...
Weekly Roundup
April 25, 2021
MEMBERS ONLY CONTENT Login or
JAMDA
April 24, 2021
Medication reconciliation has become standard care to prevent medication transfer errors. However, this process is time-consuming but could be more efficient when patients are engaged in medication reconciliation via a patient portal.
Policy Snapshot
April 23, 2021
The Measure Applications Partnership (MAP) Call for Nominations for organizations and individual subject matter experts is open. The MAP is a public-private partnership convened by NQF to provide input to the U.S. Department of Health and Human...
Policy Snapshot
April 23, 2021
In late April, the Centers for Medicare & Medicaid Services (CMS) will issue a Comparative Billing Report (CBR) on Part B claims for chronic care management. Use the data-driven tables to compare your billing and payment patterns with peers in...
Policy Snapshot
April 23, 2021
CMS revised the Medicare Learning Network Medicare Wellness Visits educational tool. Learn about: Annual wellness visit Initial preventive physical examination FAQs and resources Many Society members have reported billing the Annual Wellness Visit...
Policy Snapshot
April 23, 2021
On April 16, the FDA revoked the Emergency Use Authorization (EUA) for bamlanivimab, when administered alone , due to a sustained increase in COVID-19 viral variants in the *United States that are resistant to this antibody therapy. The FDA...
JAMDA
April 23, 2021
We aimed to establish an explicit list of potentially clinically significant drug-drug interactions (DDIs) in people aged ≥65 years.